Clinical Trials Browser

Observational × Diffusion Magnetic Resonance Imaging × Clear all

Glioblastoma, Glioma

NCT05573451 2024-09-25

CANNES

Active not recruiting

91 enrolled

Gynecologic

Uterine Cervical Neoplasms, Lymphatic Metastasis

NCT05868928 2024-05-14

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Recruiting

132 enrolled

CNS

Brain Neoplasms, Recurrence

NCT04759235 2021-02-18

Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC

Unknown

118 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02125448 2020-11-16

PRIOR

Completed

30 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03474341 2020-11-16

PRIDE

Unknown

200 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms

NCT02274480 2020-09-04

Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity

Completed

28 enrolled

Breast

Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients

NCT01836484 2020-02-13

MAPPING

Completed

162 enrolled

GynecologicLymphoid

Uterine Cervical Neoplasms, Disease, Lymphoma, Follicular, Endometrial Neoplasms

NCT02527057 2016-08-17

Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer

Unknown

90 enrolled

Gastrointestinal

Esophageal Neoplasms

Clinical Trials

APT-HGG

CANNES

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC

PRIOR

PRIDE

Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity

MAPPING

Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer